Merit Medical Q2 FY26 GAAP EPS rises 20% to USD 0.65; revenue increases 10% to USD 418.8 million

MMSI•2026-07-30

Q2 results and margin expansion

Merit Medical Systems posted second-quarter 2026 net income of USD 38.8 million, up 19.09%, with GAAP EPS at USD 0.65, up 20%.

Revenue rose 10% to USD 418.8 million, while GAAP operating margin widened 2.1 percentage points to 14.4%.

Cash flow, outlook and management commentary

Cash flow from operations fell 11% to USD 110 million year-to-date, with free cash flow down 14% to USD 76.6 million.

CEO Martha G. Aronson said results beat the high end of expectations, citing 9% organic constant-currency growth excluding a strategic divestiture.

Full-year 2026 guidance was raised to revenue of USD 1.631 billion to USD 1.643 billion, with non-GAAP EPS seen at USD 4.25 to USD 4.35.

Merit Medical Q2 FY26 GAAP EPS rises 20% to USD 0.65; revenue increases 10% to USD 418.8 million

Q2 results and margin expansion

Cash flow, outlook and management commentary

Related News

CytomX Therapeutics director Charles S. Fuchs files initial beneficial ownership statement

Ares, PIMCO commit over $2 billion to Eni in long-term upstream infrastructure partnership

Vale sets BRL 8.64 billion shareholder payout for Sept. 2

Reddit flags volatile search referrals as US user growth slows

Better Home & Finance expands Credit Karma partnership to offer HELOCs